Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 236
of 12Next
1:

Revealing the intricacies of cancer.

Verhagen AM, Lock P.

Genome Biol. 2002;3(6):REPORTS4015. Epub 2002 May 13. No abstract available.

PMID: 12093370 [PubMed - indexed for MEDLINE]

2:

Cancer genetics.

Knudson AG.

Am J Med Genet. 2002 Jul 22;111(1):96-102. Review.

PMID: 12124744 [PubMed - indexed for MEDLINE]

3:

Cancer genes and the pathways they control.

Vogelstein B, Kinzler KW.

Nat Med. 2004 Aug;10(8):789-99. Review.

PMID: 15286780 [PubMed - indexed for MEDLINE]

4:

Negative control elements of the cell cycle in human tumors.

Adams PD, Kaelin WG Jr.

Curr Opin Cell Biol. 1998 Dec;10(6):791-7. Review.

PMID: 9914179 [PubMed - indexed for MEDLINE]

5:

[Cancer genetics. A review of oncological molecular biology seen in relation to the human genome]

Gerdes AM.

Ugeskr Laeger. 2002 May 27;164(22):2865-71. Review. Danish.

PMID: 12082811 [PubMed - indexed for MEDLINE]

6:

To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?

Workman P.

Hum Exp Toxicol. 1995 Feb;14(2):222-5. Review. No abstract available.

PMID: 7779451 [PubMed - indexed for MEDLINE]

7:

Living with p53, dying of p53.

Aylon Y, Oren M.

Cell. 2007 Aug 24;130(4):597-600. Review.

PMID: 17719538 [PubMed - indexed for MEDLINE]

8:

p53 and retinoblastoma pathways in bladder cancer.

Mitra AP, Birkhahn M, Cote RJ.

World J Urol. 2007 Dec;25(6):563-71. Epub 2007 Aug 21. Review.

PMID: 17710407 [PubMed - indexed for MEDLINE]

9:

The p53 tumour suppressor protein.

Hickman ES, Helin K.

Biotechnol Genet Eng Rev. 2000;17:179-211. Review. No abstract available.

PMID: 11255666 [PubMed - indexed for MEDLINE]

10:

The cell cycle: accelerators, brakes, and checkpoints.

Ivanchuk SM, Rutka JT.

Neurosurgery. 2004 Mar;54(3):692-9; discussion 699-700. Review.

PMID: 15028146 [PubMed - indexed for MEDLINE]

11:

Cell cycle control and cancer.

Sherr CJ.

Harvey Lect. 2000-2001;96:73-92. Review. No abstract available.

PMID: 12200872 [PubMed - indexed for MEDLINE]

12:

[Oncogene and tumor suppressor gene]

Watanabe N.

Rinsho Byori. 2002 Nov;Suppl 123:131-6. Review. Japanese.

PMID: 12652800 [PubMed - indexed for MEDLINE]

13:

[DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer]

Tsuchida N, Gao C, Tsuchida Y, Nakajima T, Nishigaki R.

Tanpakushitsu Kakusan Koso. 2000 Jul;45(10):1742-51. Review. Japanese. No abstract available.

PMID: 10897687 [PubMed - indexed for MEDLINE]

14:

[TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later]

Hainaut P.

Bull Cancer. 2000 Jan;87(1):11-8. French. No abstract available.

PMID: 10673626 [PubMed - indexed for MEDLINE]

15:

Reversibility of oncogene-induced cancer.

Felsher DW.

Curr Opin Genet Dev. 2004 Feb;14(1):37-42. Review.

PMID: 15108803 [PubMed - indexed for MEDLINE]

16:

Principles of tumor suppression.

Sherr CJ.

Cell. 2004 Jan 23;116(2):235-46. Review.

PMID: 14744434 [PubMed - indexed for MEDLINE]

17:

p53: a two-faced cancer gene.

Kastan MB, Berkovich E.

Nat Cell Biol. 2007 May;9(5):489-91. No abstract available.

PMID: 17473858 [PubMed - indexed for MEDLINE]

18:

Aneuploidy-cancer predisposition syndromes: a new link between the mitotic spindle checkpoint and cancer.

Hanks S, Rahman N.

Cell Cycle. 2005 Feb;4(2):225-7. Epub 2005 Feb 3.

PMID: 15655355 [PubMed - indexed for MEDLINE]

19:

The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling.

Lo PK, Huang SZ, Chen HC, Wang FF.

Cancer Res. 2004 Dec 1;64(23):8736-45.

PMID: 15574785 [PubMed - indexed for MEDLINE]

20:

p53 mutation heterogeneity in cancer.

Soussi T, Lozano G.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. Review.

PMID: 15865939 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 236
of 12Next